BPG is committed to discovery and dissemination of knowledge
Minireviews
©The Author(s) 2023.
World J Psychiatry. Apr 19, 2023; 13(4): 141-148
Published online Apr 19, 2023. doi: 10.5498/wjp.v13.i4.141
Figure 3
Figure 3 Schematic representation of the proposed role of the kynurenine pathway in the pathophysiology of major depressive disorder. Mutual interactions between serotonergic and glutamatergic functions are indicated by the bidirectional arrows for increased or decreased function. MDD: Major depressive disorder; KMO: Kynurenine monooxygenase; Trp: Tryptophan; IDO: Indoleamine 2,3-dioxygenase; TDO: Tryptophan 2,3-dioxygenase; IFN: Interferon; IL: Interleukin.


Write to the Help Desk